Latest Whitepapers

Whitepaper
Mastering iNK Cell Generation from PSC Spheroids: A Streamlined Protocol
This app note presents a novel protocol for generating larger quantities of invariant NK (iNK) cells from pluripotent stem cells (PSCs) using cytokine cocktails.

Whitepaper
Advances in Liquid Biopsies: Improving Sensitivity and Earlier Detection
Liquid biopsies are a minimally invasive alternative that can detect the presence of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as tumor biomarkers.

Whitepaper
Microbial Monitoring for Biopharma Manufacturing
In this article to learn more about detecting contamination during bioprocessing, contamination’s influence on product quality and safety and emerging methods for detecting microbial contaminations.

Whitepaper
Make or Buy: A Strategic Decision for Lab Automation Instruments
.

Whitepaper
Data Integrity: The Heart of Laboratory Compliance
This whitepaper explores the regulatory landscape on data integrity, identifies industry challenges and offers solutions for maintaining compliance.

Whitepaper
Data Integrity and Compliance Solutions for Drug Manufacturers
This whitepaper reviews the data integrity and computer system validation (CSV) regulatory landscape in the US and EU, identifies industry trends and challenges and offers best practices for maintaining compliance.

Whitepaper
Digital Solutions To Protect Pharmaceutical Data
This whitepaper explores the regulatory environment surrounding data integrity, and what to look for in a laboratory information management system (LIMS) to ensure compliance.

Whitepaper
Proactive Solutions for Risk Mitigation in IVD Manufacturing
This whitepaper explores the need for transparency between suppliers and manufacturers, ensuring the integrity of their products and maintaining trust among consumers and regulatory authorities alike.

Whitepaper
Key Considerations for Scale-Up and Outsourcing in Biopharma
As biopharmaceutical companies scale up manufacturing, many are turning to outsourcing for buffer and process liquid preparation. But before making this decision, organizations must carefully weigh up various factors, including manufacturing space, personnel requirements and analytical capabilities.

Whitepaper
How To Accelerate Vaccine Production – And Avoid Speed Bumps
This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.
Advertisement